Provided by Tiger Fintech (Singapore) Pte. Ltd.

COSMOS HEALTH INC

0.4269
-0.0100-2.29%
Post-market: 0.43670.0098+2.30%19:20 EDT
Volume:56.22K
Turnover:24.18K
Market Cap:12.24M
PE:-0.43
High:0.4437
Open:0.4400
Low:0.4210
Close:0.4369
Loading ...

BRIEF-Cosmos Health To Start US Production At GMP-Certified Facilities

Reuters
·
24 Jun

Cosmos Health Enters U.S. Market with Strategic Manufacturing Deal with DolCas Biotech

Reuters
·
24 Jun

Cosmos Health Enters U.S. Market With Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement With New Jersey-Based Dolcas Biotech

THOMSON REUTERS
·
24 Jun

Cosmos Health Inc - to Start U.S. Production at Gmp-Certified Facilities

THOMSON REUTERS
·
24 Jun

Grigorios Siokas, CEO of Cosmos Health Inc., Reports Acquisition of Common Shares

Reuters
·
27 May

Grigorios Siokas, CEO, Reports Acquisition of Common Shares in Cosmos Health Inc

Reuters
·
24 May

CEO Grigorios Siokas Reports Acquisition of Common Shares in Cosmos Health Inc

Reuters
·
20 May

Cosmos Health Reports Q1 2025: Gross Profit Up 54%, Adjusted Net Income Turns Positive at $0.28M, Revenue Declines Slightly

Reuters
·
16 May

Retransmission – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

THOMSON REUTERS
·
16 May

Cosmos Health reports Q1 EPS (3c) vs. (11c) last year

TIPRANKS
·
15 May

Cosmos Health Q1 EPS $(0.03) Up From $(0.11) YoY, Sales $13.71M Down From $14.58M YoY

Benzinga
·
15 May

BRIEF-Cosmos Health Q1 Adjusted EBITDA USD 370 Thousand

Reuters
·
15 May

BRIEF-Cosmos Health Q1 Revenue USD 13.71 Million

Reuters
·
15 May

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

THOMSON REUTERS
·
15 May

Cosmos Health Q1 Revenue USD 13.71 Million

THOMSON REUTERS
·
15 May

Press Release: Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Dow Jones
·
15 May

Cosmos Health Receives Additional Sky Premium Life Order From Pharmalink

MT Newswires Live
·
08 May

Cosmos Health Secures 80,000-Unit Follow-Up Order from Pharmalink in UAE for Sky Premium Life Products

Reuters
·
08 May

Cosmos Health Secures Follow-up Order From Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-Unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

THOMSON REUTERS
·
08 May

BRIEF-Cosmos Health Receives Additional 180-Day Compliance Period From Nasdaq

Reuters
·
07 May